Park Ha Biological (NASDAQ: PHH) files 6-K on 2025 annual general meeting materials

Rhea-AI Filing Summary

Park Ha Biological Technology Co., Ltd. filed a Form 6-K related to its 2025 annual general meeting. The company is furnishing a formal notice of the 2025 annual general meeting dated September 12, 2025 and a form of proxy card to be mailed to shareholders. These materials are intended to inform shareholders about the meeting and enable them to vote, either in person or by proxy.

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

_______________

FORM 6-K

_______________

REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of September 2025

_______________

Park Ha Biological Technology Co., Ltd.

(Exact name of registrant as specified in its charter)

_______________

901, Building C
Phase 2, Wuxi International Life Science Innovation Campus
196 Jinghui East Road
Xinwu District, Wuxi, Jiangsu Province
People’s Republic of China 214000

(Address of Principal Executive Office)

_______________

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒            Form 40-F ☐

2025 Annual General Meeting

In connection with the 2025 annual general meeting of Park Ha Biological Technology Co., Ltd., a Cayman Islands company (the “Company”), the Company hereby furnishes the following documents:

Exhibits

Exhibit No.		Description
99.1		Notice of 2025 Annual General Meeting, dated September 12, 2025, to be mailed to the shareholders of the Company
99.2		Form of Proxy Card to be mailed to the shareholders of the Company

1

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Dated: September 18, 2025

		Park Ha Biological Technology Co., Ltd.
		By:		/s/ Xiaoqiu Zhang
		Name:		Xiaoqiu Zhang
		Title:		Chief Executive Officer and Chairperson of the Board

2

FAQ

What did Park Ha Biological Technology Co., Ltd. (PHH) disclose in this Form 6-K?

The company furnished materials related to its 2025 annual general meeting, including a notice of meeting dated September 12, 2025 and a form of proxy card for shareholders.

What exhibits are included with Park Ha Biological Technology (PHH)'s 2025 AGM filing?

The filing lists two exhibits: Exhibit 99.1, the Notice of 2025 Annual General Meeting dated September 12, 2025, and Exhibit 99.2, the Form of Proxy Card to be mailed to shareholders.

What is the purpose of the proxy card mentioned in the PHH Form 6-K?

The proxy card is provided so shareholders of Park Ha Biological Technology Co., Ltd. can appoint a proxy to vote their shares on matters to be presented at the 2025 annual general meeting.

Who signed the Form 6-K for Park Ha Biological Technology Co., Ltd. (PHH)?

The report was signed on behalf of the company by Xiaoqiu Zhang, who serves as Chief Executive Officer and Chairperson of the Board.

When are the 2025 annual general meeting materials for PHH dated?

The Notice of 2025 Annual General Meeting is dated September 12, 2025, and the Form 6-K itself is dated September 18, 2025.

Where is Park Ha Biological Technology Co., Ltd. headquartered?

The principal executive office is located at 901, Building C Phase 2, Wuxi International Life Science Innovation Campus, 196 Jinghui East Road, Xinwu District, Wuxi, Jiangsu Province, People’s Republic of China 214000.